A Director at CVS Health (NYSE: CVS) is Buying Shares

Today, a Director at CVS Health (NYSE: CVS), David C. Brown, bought shares of CVS for $619.9K.

Following David C. Brown’s last CVS Buy transaction on March 16, 2012, the stock climbed by 22.6%. This recent transaction increases David C. Brown’s holding in the company by 10.96% to a total of $6.39 million.

See today’s analyst top recommended stocks >>

Based on CVS Health’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $45.69 billion and quarterly net profit of $996 million. In comparison, last year the company earned revenue of $44.51 billion and had a net profit of $948 million. CVS’s market cap is $64.11B and the company has a P/E ratio of 9.66. Currently, CVS Health has an average volume of 1.87M.

32 different firms, including Argus Research and B.Riley FBR, currently also have a Buy rating on the stock. Based on 10 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $84.90, reflecting a -25.7% downside.

The insider sentiment on CVS Health has been negative according to 42 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

David C. Brown’s trades have generated a 20.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts